BNP PARIBAS FINANCIAL MARKETS - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 126 filers reported holding ANAPTYSBIO INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$427,394
+8.1%
23,797
+22.5%
0.00%
Q2 2023$395,227
-44.2%
19,431
-40.3%
0.00%
-100.0%
Q1 2023$708,614
+44.8%
32,565
+106.2%
0.00%0.0%
Q4 2022$489,332
-99.9%
15,790
-47.7%
0.00%0.0%
Q3 2022$770,479,000
+661.5%
30,203
+506.0%
0.00%
Q2 2022$101,175,000
+43.9%
4,984
+75.4%
0.00%
Q1 2022$70,311,000
-73.8%
2,842
-63.2%
0.00%
Q4 2021$268,722,000
+97.8%
7,733
+54.4%
0.00%
Q3 2021$135,844,000
+88.0%
5,009
+79.7%
0.00%
Q2 2021$72,267,000
-92.8%
2,787
-79.4%
0.00%
-100.0%
Q1 2021$1,008,518,000
+2033.2%
13,535
+515.5%
0.00%
Q4 2020$47,278,000
-33.0%
2,199
-54.0%
0.00%
Q3 2020$70,579,000
-13.3%
4,785
+31.4%
0.00%
Q2 2020$81,362,000
-73.5%
3,642
-83.2%
0.00%
-100.0%
Q1 2020$306,451,000
+454.3%
21,688
+537.5%
0.00%
Q4 2019$55,282,000
-63.4%
3,402
-21.2%
0.00%
Q3 2019$151,052,000
-5.5%
4,317
+52.3%
0.00%
Q2 2019$159,894,000
-54.1%
2,834
-40.6%
0.00%
-100.0%
Q1 2019$348,448,000
+1337.5%
4,770
+1155.3%
0.00%
Q4 2018$24,240,000
-75.9%
380
-62.4%
0.00%
Q3 2018$100,768,000
+51.2%
1,010
+7.7%
0.00%
Q2 2018$66,636,000
-82.4%
938
-74.2%
0.00%
-100.0%
Q1 2018$378,539,000
-86.8%
3,637
-87.2%
0.00%
-80.0%
Q4 2017$2,866,390,000
+6700.5%
28,459
+2259.8%
0.01%
Q3 2017$42,150,000
+233.6%
1,206
+128.4%
0.00%
Q2 2017$12,635,0005280.00%
Other shareholders
ANAPTYSBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,950,609$35,032,9384.94%
EcoR1 Capital, LLC 7,521,024$135,077,5914.56%
Saturn V Capital Management LP 577,101$10,364,7344.34%
GREAT POINT PARTNERS LLC 894,333$16,062,2212.93%
5AM Venture Management, LLC 357,733$6,424,8851.85%
First Light Asset Management, LLC 790,806$14,202,8761.35%
Boxer Capital, LLC 1,300,000$23,348,0001.24%
Frazier Life Sciences Management, L.P. 899,700$16,158,6121.07%
Deep Track Capital, LP 1,345,813$24,170,8010.93%
Palo Alto Investors LP 431,224$7,744,7830.73%
View complete list of ANAPTYSBIO INC shareholders